Intensive Systolic Blood Pressure Lowering and Kidney Disease Progression in IgA Nephropathy: A Cohort Study

Hypertension has been shown to be an important risk factor in IgA nephropathy (IgAN). The 2021 the Kidney Disease Improving Global Outcomes (KDIGO) Guideline proposes a target systolic blood pressure (SBP) of less than 120 mmHg in patients with Chronic Kidney Disease (CKD) not receiving dialysis. Ho...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2022-02, Vol.9, p.813603-813603
Main Authors: Yu, Guizhen, Cheng, Jun, Jiang, Yan, Li, Heng, Li, Xiayu, Chen, Jianghua
Format: Article
Language:English
Subjects:
IgA nephropathy
kidney failure
Medicine
proteinuria
renoprotective
systolic blood pressure
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hypertension has been shown to be an important risk factor in IgA nephropathy (IgAN). The 2021 the Kidney Disease Improving Global Outcomes (KDIGO) Guideline proposes a target systolic blood pressure (SBP) of less than 120 mmHg in patients with Chronic Kidney Disease (CKD) not receiving dialysis. However, whether lowering SBP from
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2022.813603